- Home
- AMWD vs MPLT Comparison
AMWD vs MPLT Comparison
Compare AMWD & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMWD | MPLT |
|---|---|---|
| Founded | 1980 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.8M | 811.3M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMWD | MPLT |
|---|---|---|
| Price | $40.21 | $28.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $59.50 | $32.67 |
| AVG Volume (30 Days) | 120.8K | ★ 308.4K |
| Earning Date | 05-28-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,709,585,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.51 | $12.24 |
| 52 Week High | $72.16 | $33.28 |
Technical Indicators
Market Signals| Indicator | AMWD | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 38.20 | 55.59 |
| Support Level | $37.44 | $27.00 |
| Resistance Level | $42.58 | $33.28 |
| Average True Range (ATR) | 1.76 | 2.56 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 2.25 | 36.99 |
Price Performance
Historical ComparisonAbout AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.